1. Home
  2. JAGX vs BTBD Comparison

JAGX vs BTBD Comparison

Compare JAGX & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • BTBD
  • Stock Information
  • Founded
  • JAGX 2013
  • BTBD 1987
  • Country
  • JAGX United States
  • BTBD United States
  • Employees
  • JAGX N/A
  • BTBD N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • BTBD Restaurants
  • Sector
  • JAGX Health Care
  • BTBD Consumer Discretionary
  • Exchange
  • JAGX Nasdaq
  • BTBD Nasdaq
  • Market Cap
  • JAGX 7.4M
  • BTBD 6.6M
  • IPO Year
  • JAGX N/A
  • BTBD 2021
  • Fundamental
  • Price
  • JAGX $5.88
  • BTBD $1.00
  • Analyst Decision
  • JAGX
  • BTBD
  • Analyst Count
  • JAGX 0
  • BTBD 0
  • Target Price
  • JAGX N/A
  • BTBD N/A
  • AVG Volume (30 Days)
  • JAGX 247.5K
  • BTBD 2.6K
  • Earning Date
  • JAGX 05-15-2025
  • BTBD 05-15-2025
  • Dividend Yield
  • JAGX N/A
  • BTBD N/A
  • EPS Growth
  • JAGX N/A
  • BTBD N/A
  • EPS
  • JAGX N/A
  • BTBD N/A
  • Revenue
  • JAGX $11,689,000.00
  • BTBD $14,864,398.00
  • Revenue This Year
  • JAGX $22.41
  • BTBD N/A
  • Revenue Next Year
  • JAGX $30.00
  • BTBD N/A
  • P/E Ratio
  • JAGX N/A
  • BTBD N/A
  • Revenue Growth
  • JAGX 19.75
  • BTBD 4.71
  • 52 Week Low
  • JAGX $4.02
  • BTBD $1.05
  • 52 Week High
  • JAGX $502.50
  • BTBD $2.02
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 37.09
  • BTBD 36.33
  • Support Level
  • JAGX $5.30
  • BTBD $1.05
  • Resistance Level
  • JAGX $13.20
  • BTBD $1.08
  • Average True Range (ATR)
  • JAGX 1.49
  • BTBD 0.03
  • MACD
  • JAGX -0.57
  • BTBD -0.00
  • Stochastic Oscillator
  • JAGX 7.30
  • BTBD 0.00

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.

Share on Social Networks: